You searched for "OIA"

620 results found

Applying for ophthalmology ST1 in 2026: What’s new?

Competition for ophthalmology ST1 has intensified steadily over recent cycles, rising from ~9:1 (2022) to ~10:1 (2023), ~14:1 (2024) and ~22:1 (2025) [1]. Against this background, applicants benefit from a structured approach: mapping achievements to portfolio domains early, identifying gaps...

Beyond the slit lamp: Unanticipated lessons from my ophthalmology elective

My six-week elective in ophthalmology at Westmead Hospital in Sydney offered much more than technical mastery; it challenged my assumptions about patient care, teaching and the role of curiosity in medicine. Though my passion for eyes was ignited by my...

Viscoelastic distension of the lacrimal sac during endoscopic dacryocystorhinostomy: A case-based technical note

Epiphora secondary to acquired nasolacrimal duct obstruction (NLDO) is a common presentation in ophthalmic practice, with an incidence of 30.47 per 100,000 population [1]. Histopathological studies demonstrate that NLDO is characterised by chronic inflammation and progressive fibrosis of the ductal...

An ophthalmology elective in Kandy, Sri Lanka

On my first day at The Centre for Sight, Kandy General Hospital, I observed an enucleation. The surgeons worked with quiet precision, preserving the extraocular muscles for prosthesis placement. But when the time came, it became clear that the prosthesis...

Learning from litigation: ocular drug toxicity

Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the sword of Damocles above us...

Strengthening eye care services in Botswana through the Botswana-Addenbrooke’s Abroad VISION 2020 LINK

The VISION 2020 LINK between Botswana and Addenbrooke’s Abroad has been running for 10 years. With support from the VISION 2020 LINKS Programme two-way exchange visits were undertaken leading to the formation of the first formal international partnership under Addenbrooke’s...

Unravelling ocular motility

Ocular motility can often be a slightly abstract concept during the earlier years of ophthalmology training. A large variance on what embodies normality; mythical concepts like fusion and binocular vision, examination techniques that can be fiddly, and complex neuroanatomy all...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Patient and public participation shapes biomedical research and access priorities in eye health

Patients, clinicians and clinician-scientists play a valuable role in shaping the future of vision research. Limited funding demands targeted research initiatives that ultimately will shape health policy and practice to secure progress in improving patient outcomes in eye health. This...

Changing the post cataract surgery review pathway – is patient safety compromised?

Cataract surgery continues to be the most commonly performed elective surgical procedure in the UK, with an annual rate of approximately 4150/100,000 people over the age of 65 accounting for a significant proportion of the surgical workload of most ophthalmologists...

COVID-19: Pete’s Bogus Journey

The author shares his personal experience of contracting coronavirus. I managed to body swerve COVID-19 for nine months. The Pfizer vaccine was being rolled out in my trust. I had my first inoculation booked in three weeks. I had survived...

Ophthalmology in a War Zone: an interview with Dr Volodymyr Melnyk

It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...